Trial Profile
Phase IIa study of CAN04 in patients with Acute myeloid leukemia
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 01 Oct 2016
Price :
$35
*
At a glance
- Drugs Nadunolimab (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 01 Oct 2016 New trial record